The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.本發明係關於新穎之通式(I)化合物，彼等之立體異構體、區域異構體、互變異構體形式及涉及彼等合成之新穎中間體，彼等之藥學上可接受之鹽、藥學上可接受之溶劑化物及含彼等之藥學組成物。本發明亦關於製備新穎之通式(I)化合物，彼等之立體異構體、區域異構體，彼等之互變異構體形式，彼等之藥學上可接受之鹽、藥學上可接受之溶劑化物、含彼等之藥學組成物、及涉及彼等合成之新穎中間體的方法。
